Trustmark National Bank Trust Department Sells 4,608 Shares of Aflac Incorporated (NYSE:AFL)

Trustmark National Bank Trust Department decreased its position in Aflac Incorporated (NYSE:AFL) by 19.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,328 shares of the financial services provider’s stock after selling 4,608 shares during the quarter. Trustmark National Bank Trust Department’s holdings in Aflac were worth $2,161,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of AFL. Strategic Financial Concepts LLC lifted its holdings in Aflac by 7,001.0% in the 2nd quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider’s stock worth $596,000 after purchasing an additional 658,303 shares in the last quarter. International Assets Investment Management LLC increased its position in Aflac by 10,878.5% in the third quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider’s stock worth $62,597,000 after purchasing an additional 554,803 shares during the last quarter. Truist Financial Corp raised its stake in Aflac by 26.6% during the second quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock valued at $172,338,000 after purchasing an additional 405,847 shares in the last quarter. Swedbank AB bought a new position in shares of Aflac in the 1st quarter valued at about $27,588,000. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Aflac by 6.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock worth $429,319,000 after purchasing an additional 285,576 shares during the period. 67.44% of the stock is owned by hedge funds and other institutional investors.

Aflac Price Performance

Shares of Aflac stock opened at $110.24 on Thursday. The firm has a market cap of $61.24 billion, a PE ratio of 16.60, a P/E/G ratio of 2.15 and a beta of 0.96. The business has a 50-day moving average price of $110.58 and a 200 day moving average price of $100.16. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. The firm had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. Aflac’s quarterly revenue was down 40.4% compared to the same quarter last year. During the same period last year, the company posted $1.84 EPS. Sell-side analysts predict that Aflac Incorporated will post 7.22 earnings per share for the current fiscal year.

Aflac Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be issued a $0.50 dividend. The ex-dividend date is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a yield of 1.81%. Aflac’s payout ratio is 30.12%.

Analysts Set New Price Targets

AFL has been the topic of a number of recent analyst reports. Barclays initiated coverage on shares of Aflac in a research report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price objective on the stock. Truist Financial boosted their price target on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a report on Friday, November 1st. Morgan Stanley raised their target price on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research report on Monday, August 19th. JPMorgan Chase & Co. raised their price objective on Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, October 3rd. Finally, Wells Fargo & Company increased their price objective on Aflac from $106.00 to $107.00 and gave the company an “equal weight” rating in a report on Tuesday, November 5th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $97.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.